ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer (Q38401463)
Jump to navigation
Jump to search
scientific article published on 21 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer |
scientific article published on 21 August 2012 |
Statements
1 reference
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer (English)
1 reference
Daniela Matei
1 reference
Ursula A Matulonis
1 reference
Julie Lee
1 reference
Brian Lasonde
1 reference
William P Tew
1 reference
Afra Yehwalashet
1 reference
Kian Behbakht
1 reference
Jill Grothusen
1 reference
Gini Fleming
1 reference
Nita K Lee
1 reference
Jamie Arnott
1 reference
Mark R Bray
1 reference
Graham Fletcher
1 reference
Richard D Brokx
1 reference
Vincent Castonguay
1 reference
Helen Mackay
1 reference
Carolyn F Sidor
1 reference
Amit M Oza
1 reference
21 August 2012
1 reference
1 reference
Identifiers
1 reference